These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7347808)

  • 21. The value of the reserpine test in psychopharmacology.
    Bourin M; Poncelet M; Chermat R; Simon P
    Arzneimittelforschung; 1983; 33(8):1173-6. PubMed ID: 6685496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ejaculation induces long-lasting behavioural changes in male rats in the forced swimming test: evidence for an increased sensitivity to the antidepressant desipramine.
    Martínez-Mota L; López-Rubalcava C; Rodríguez-Manzo G
    Brain Res Bull; 2005 Apr; 65(4):323-9. PubMed ID: 15811598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the interaction of antidepressant drugs with adrenocorticotropic hormone or prednisone in rats.
    Pietrasiewicz T; Zebrowska-Lupina I
    Pol J Pharmacol; 1996; 48(2):145-52. PubMed ID: 9112644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the metabolism of cocaine by SKF-525A.
    Estevez VS; Ho BT; Englert LF
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):179-82. PubMed ID: 877402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain desipramine level in relation to the anti-reserpine acitivity of imipramine.
    Jori A; Bernardi D
    J Pharm Pharmacol; 1968 Dec; 20(12):955-6. PubMed ID: 4388340
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of desipramine on thyroid hormone metabolism in rat brain.
    Campos-Barros A; Meinhold H; Stula M; Müller F; Köhler R; Eravci M; Putzien O; Baumgartner A
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1143-52. PubMed ID: 8138928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptation of the tail suspension test to the rat.
    Chermat R; Thierry B; Mico JA; Steru L; Simon P
    J Pharmacol; 1986; 17(3):348-50. PubMed ID: 3795979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of behavioral effects of electroconvulsive shock but not those of desipramine by the selective 5-HT-3 receptor antagonist, ondansetron.
    Kostowski W; Płaźnik A; Nazar M; Jessa M
    Pol J Pharmacol; 1995; 47(2):193-5. PubMed ID: 8688895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
    Kolasiewicz W; Maj J
    Pol J Pharmacol; 1996; 48(5):467-79. PubMed ID: 9112688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
    Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
    J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile desipramine reduces adult sensitivity to imipramine in two behavioral tests.
    Dwyer KD; Roy EJ
    Pharmacol Biochem Behav; 1993 May; 45(1):201-7. PubMed ID: 8516359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic treatment with imipramine: further functional evidence for the enhanced noradrenergic transmission in flexor reflex activity.
    Maj J; Górka Z; Melzacka M; Rawłów A; Pilc A
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):256-60. PubMed ID: 6306487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
    DeVane CL; Simpkins JW; Stout SA
    Psychopharmacology (Berl); 1984; 84(2):225-30. PubMed ID: 6438681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.
    Rogóz Z; Dlaboga D; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2003 Jun; 54(2):257-70. PubMed ID: 12832726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low alcohol dose on behavioral "despair" in rats neonatally treated with antidepressant drugs.
    Fernandez-Pardal J; Hilakivi LA
    Alcohol; 1989; 6(2):93-5. PubMed ID: 2713092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the central effects of M-14012-A and SKF-525-A in rodents].
    Garrido J; Pérez Naranjo J; Martínez Roldán C
    Arch Farmacol Toxicol; 1983 Aug; 9(2):191-202. PubMed ID: 6660935
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and pharmacological properties of 13H-naphtho[1',2':7,6] [1,4] diazepino[2,3-b] pyridines.
    Kaczmarek L; Nantka-Namirski P; Dereń A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(2):165-75. PubMed ID: 2274474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of chlorpromazine, metyrapone, imipramine and SKF 525-A on the hepatic first pass elimination of propranolol in the pithed rat.
    Barber HE; Kitteringham NR; Petrie JC
    Br J Pharmacol; 1982 Dec; 77(4):667-77. PubMed ID: 7150874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.